Proscia Raises $23M in Series B Funding Led by Scale Venture Partners
![](https://www.signifyresearch.net/wp-content/uploads/2020/12/Picture4-624x397-1.png)
![Steve Holloway headshot](https://www.signifyresearch.net/wp-content/uploads/2023/12/Signify-Steve_H-Profile-@2-150x150.png)
Steve Holloway
Published: December 1, 2020 In The News
December 1, 2020 – Proscia, a leading provider of digital and computational pathology solutions, has secured $23 million in Series B funding led by Scale Venture Partners, with participation from Hitachi Ventures, the strategic corporate venture capital arm of Hitachi, Ltd., bringing its funding total to $35 million. The company will use the investment to accelerate its global growth and strengthen its position of leadership in transforming cancer research and diagnosis at a time when demand for modernizing pathology is higher than ever.
You may also like